Trials / Completed
CompletedNCT01296958
Targeted Screening for Taenia Solium Tapeworms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,811 (actual)
- Sponsor
- Oregon Health and Science University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether screening and treatment of tapeworm carriers can decrease community transmission of Taenia solium parasitic infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Niclosamide | Single oral dose of niclosamide determined by weight (dose: 11 to 34kg receive 1 gram, 35 to 50kg receive 1.5 grams, over 50kg receive 2 grams) |
| BEHAVIORAL | Community education campaign | Education about prevention of Taenia solium infection provided in a single short (20 minute) interaction with the participant. Education was verbal with visual aids. |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2011-02-16
- Last updated
- 2014-10-24
Locations
1 site across 1 country: Peru
Source: ClinicalTrials.gov record NCT01296958. Inclusion in this directory is not an endorsement.